
On May 23, 2025, NVIC submitted a written public comment to the US Food and Drug Administration’s Vaccines & Related Biological Products Advisory Committee (VRBPAC) signed by two former consumer...

The FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend updating the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain, citing the current vaccine's ineffectiveness against emerging variants. Despite the absence of safety data, the committee emphasized the importance of vaccine effectiveness, while noting the potential for rapid variant evolution which might impact vaccine efficacy. Manufacturers like Moderna, Pfizer, and Novavax presented promising data for their new vaccine candidates, with an emphasis on preparedness to meet the FDA's upcoming strain decision.

Stay informed on impending changes to vaccine injury compensation with Theresa Wrangham's latest article. Learn about the expected release of a pivotal report by the National Academy of Medicine and its potential impact on the Vaccine Injury Table, alongside updates on membership vacancies and compensation trends.
.png)
Learn about the ACIP recommendation for Pfizer's Abrysvo RSV vaccine in pregnant women, the controversy surrounding its testing, and the potential impact on preterm births – all in our eye-opening article on RSV vaccination strategies.

Learn about CDC's treatment of the RSV drug nirsevimab as a vaccine and potential impacts to vaccine mandates, tracking and injury compensation.

Read NVIC's referenced public comment on FDA future COVID-19 regimens and call for withdrawal of mRNA COVID-19 vaccines.

Learn about the implications of the addition of COVID-19 vaccines to the federal vaccine schedules and implications for vaccine injury compensation.

Learn about ACIP's October 2022 vote to add COVID-19 to the childhood vaccination schedule.

On Nov. 14, 1986, President Ronald Reagan signed the National Childhood Vaccine Injury Act of 1986 into law, instituting first-time vaccine safety reforms in the U.S. vaccination system and creating...
NVIC to FDA: mRNA COVID-19 Shots Should Not Be Recommended for Anyone
On May 23, 2025, NVIC submitted a written public comment to the US Food and Drug Administration’s Vaccines & Related Biological Products Advisory Committee (VRBPAC) signed by two former consumer...